PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Composite Nanoparticles
Inquiry

Composite Nanoparticles

Inquiry
Cat. No. Product Name Inquiry
X26-06-ZQ4861 Cyanine 3.5-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-Cy3.5)
X26-06-ZQ4862 Rapamycin-loaded PLGA nanoparticles surface-modified with galactose (PLGA(Rapamycin)@Galactose)
X26-06-ZQ4863 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Cy5.5 (PLGA@MSNs(DOX)@Cy5.5)
X26-06-ZQ4864 TRITC-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-TRITC)
X26-06-ZQ4865 PLGA-encapsulated indocyanine green/doxorubicin co-loaded mesoporous silica nanoparticles (PLGA@MSNs(DOX/ICG))
X26-06-ZQ4866 Rhodamine B-labeled TAT peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@TAT-RB)
X26-06-ZQ4867 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Cy5 (PLGA@MSNs(DOX)@Cy5)
X26-06-ZQ4868 Rhodamine B-labeled SSMDIVLRAPLM peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@SSMDIVLRAPLM-RB)
X26-06-ZQ4869 FITC-labeled TAT peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@TAT-FITC)
X26-06-ZQ4870 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with glycyrrhetinic acid (PLGA@MSNs(DOX)@GA)
X26-06-ZQ4871 Cyanine 3-labeled SSMDIVLRAPLM peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@SSMDIVLRAPLM-Cy3)
X26-06-ZQ4872 Cyanine 5.5-labeled SSMDIVLRAPLM peptide-modified doxorubicin-loaded PLGA nanoparticles (PLGA(DOX)@SSMDIVLRAPLM-Cy5.5)
X26-06-ZQ4873 Rapamycin-loaded PLGA nanoparticles surface-modified with triphenylphosphonium (PLGA(Rapamycin)@TPP)
X26-06-ZQ4874 Rapamycin-loaded PLGA nanoparticles surface-modified with mannose (PLGA(Rapamycin)@Mannose)
X26-06-ZQ4875 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Cy3 (PLGA@MSNs(DOX)@Cy3)
X26-06-ZQ4876 Indocyanine green/doxorubicin co-loaded PLGA nanoparticles surface-modified with mannose (PLGA(DOX/ICG)@Mannose)
X26-06-ZQ4877 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Cy7 (PLGA@MSNs(DOX)@Cy7)
X26-06-ZQ4878 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with Rhodamine B (PLGA@MSNs(DOX)@RB)
X26-06-ZQ4879 Cyanine 7-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-Cy7)
X26-06-ZQ4880 Rapamycin-loaded PLGA nanoparticles surface-modified with KRWWKWWRR antimicrobial peptide (PLGA(Rapamycin)@KRWWKWWRR)
X26-06-ZQ4881 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with chitosan (PLGA@MSNs(DOX)@Chitosan)
X26-06-ZQ4882 Rapamycin-loaded PLGA nanoparticles surface-modified with Angiopep-2 (PLGA(Rapamycin)@Angiopep-2)
X26-06-ZQ4883 NBD-labeled rapamycin-loaded PLGA nanoparticles (PLGA(Rapamycin)-NBD)
X26-06-ZQ4884 pH-responsive PLGA nanoparticles surface-modified with NGR peptide (pH-PLGA@NGR)
X26-06-ZQ4885 pH-responsive FITC-labeled doxorubicin-loaded PLGA nanoparticles surface-modified with NGR peptide (pH-PLGA(DOX)-FITC@NGR)
X26-06-ZQ4886 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with RGD peptide (PLGA@MSNs(DOX)@RGD)
X26-06-ZQ4887 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with cRGDfk peptide (PLGA@MSNs(DOX)@cRGDfk)
X26-06-ZQ4888 pH-responsive Cyanine 7-labeled PLGA nanoparticles (pH-PLGA-Cy7)
X26-06-ZQ4889 pH-responsive Cyanine 5-labeled PLGA nanoparticles (pH-PLGA-Cy5)
X26-06-ZQ4890 pH-responsive Rhodamine B-labeled curcumin-loaded PLGA nanoparticles (100 nm) (pH-PLGA(Cur)-RB)
X26-06-ZQ4891 pH-responsive PLGA nanoparticles surface-modified with ciprofloxacin (pH-PLGA@Ciprofloxacin)
X26-06-ZQ4892 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with dextran (PLGA@MSNs(DOX)@Dextran)
X26-06-ZQ4893 pH-responsive Cyanine 5.5-labeled PLGA nanoparticles (pH-PLGA-Cy5.5)
X26-06-ZQ4894 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with NGR peptide (PLGA@MSNs(DOX)@NGR)
X26-06-ZQ4895 pH-responsive FITC-labeled PLGA nanoparticles (pH-PLGA-FITC)
X26-06-ZQ4896 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with metronidazole (PLGA@MSNs(DOX)@Metronidazole)
X26-06-ZQ4897 PLGA-encapsulated doxorubicin-loaded mesoporous silica nanoparticles surface-modified with SSMDIVLRAPLM peptide (PLGA@MSNs(DOX)@SSMDIVLRAPLM)
X26-06-ZQ4898 pH-responsive indocyanine green-loaded PLGA nanoparticles (pH-PLGA(ICG))
X26-06-ZQ4899 pH-responsive FITC-labeled curcumin-loaded PLGA nanoparticles (100 nm) (pH-PLGA(Cur)-FITC)
X26-06-ZQ4900 pH-responsive NBD-labeled PLGA nanoparticles (pH-PLGA-NBD)
PRODUCTS
Featured Products
Nucleic Acid Drug Delivery Products
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010) GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011) GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012) GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014) Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015) Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016) Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017) GalNAc-L96-OH (Cat#: X24-11-YM018) GalNAc-L96-TEA (Cat#: X24-11-YM019)
Hots Products
N-Glycan
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036) A2G2 N-Glycan (Cat#: X23-03-YW037) A2G2S2 N-Glycan (Cat#: X23-03-YW038) A2 N-Glycan (Cat#: X23-03-YW039) A2[6]G1 N-Glycan (Cat#: X23-03-YW040) M3 N-Glycan (Cat#: X23-03-YW041) A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
O-Glycan
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178) Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179) Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180) Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181) Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182) T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192) T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193) Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood Group and Lewis Antigen
Blood group A trisaccharide (Cat#: XCO0060Q) Blood group B trisaccharide (Cat#: XCO0068Q) Blood group H disaccharide (Cat#: XCO0074Q) Lewis A trisaccharide (Cat#: XCO0079Q) 3'-Sulfated lewis A (Cat#: XCO0080Q) Lewis B tetrasaccharide (Cat#: XCO0083Q) Lewis X trisaccharide (Cat#: XCO0085Q) Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Human Milk Oligosaccharides (HMOs)
Lacto-N-biose (Cat#: XCO0089Q) 2'-Fucosyllactose (Cat#: XCO0091Q) 3-Fucosyllactose (Cat#: XCO0092Q) Lactodifucotetraose (Cat#: XCO0093Q) Lacto-N-triose I (Cat#: XCO0094Q) 3'-Sialyllactose sodium salt (Cat#: XCO0096Q) 6'-Sialyllactose sodium salt (Cat#: XCO0098Q) 3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Glycosaminoglycans
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478) FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480) TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481) Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482) Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598) Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611) Heparin disaccharide I-A (Cat#: X22-11-ZQ662) Chondroitine sulfate (Cat#: X23-04-XQ1118)
Carbohydrate Conjugates
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008) Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037) Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038) Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039) Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
Glycolipids
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101) GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112) LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118) Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131) Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146) Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162) Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175) nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Cyclodextrin
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119) Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003) Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004) Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005) Succinyl-γ-cyclodextrin (Cat#: X23-11-B006) ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007) β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008) γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Dextran
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273) Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279) FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280) FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283) TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287) FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291) Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377) TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383) Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.